folder

Familial Alzheimer disease mutation identifies novel role of SORLA in release of neurotrophic exosomes

Authors

  • Kristian Juul-Madsen
  • Ina-Maria Rudolph
  • Jemila P. Gomes
  • Katrina Meyer
  • Peter L. Ovesen
  • Malgorzata Gorniak-Walas
  • Marianna Kokoli
  • Narasimha S. Telugu
  • Malthe vonTangen Sivertsen
  • Fabia Febbraro
  • Duncan S. Sutherland
  • Johan Palmfeldt
  • Sebastian Diecke
  • Olav M. Andersen
  • Matthias Selbach
  • Thomas E. Willnow

Journal

  • Alzheimer's & Dementia

Citation

  • Alzheimers Dement 21 (9): e70591

Abstract

  • INTRODUCTION: Mutations in SORL1, encoding the sorting receptor Sortilin-related receptor with A-type repeats (SORLA), are found in individuals with Alzheimer's disease (AD). We studied SORLA(N1358S), carrying a mutation in its ligand binding domain, to learn more about receptor functions relevant for human brain health. METHODS: We investigated consequences of SORLA(N1358S) expression in induced pluripotent stem cell (iPSC)-derived human neurons and microglia, using unbiased proteome screens and functional cell assays. RESULTS:
    We identified alterations in the SORLA(N1358S) interactome linked to biogenesis of exosomes. Consequently, the mutant receptor failed to promote release and neurotrophic qualities of exosomes, a defect attributed to altered exosomal content of microRNAs controlling neuronal maturation. DISCUSSION: We identified a role for SORLA in controlling quantity and neurotrophic quality of exosomes secreted by cells, suggesting impaired cellular cross talk through exosomes as a pathological trait contributing to AD pathology in carriers of SORL1 variants.


DOI

doi:10.1002/alz.70591